美晨科技(300237.SZ):擬1167萬元收購湖北東美32.68%股權
格隆匯2月17日丨美晨科技(300237.SZ)公佈,公司擬以自有資金收購青島曦晨企業管理合夥企業(有限合夥)(簡稱“青島曦晨”)持有的湖北東美汽車零部件有限公司(簡稱“湖北東美”或“標的公司”)32.68%的股權。本次交易完成後,公司將直接持有湖北東美 32.68%的股權,通過全資子公司山東美晨工業集團有限公司(以下簡稱“美晨工業”)間接持有湖北東美 38.98%股權,合計持有湖北東美 71.66%的股權,湖北東美將納入公司合併報表範圍。經交易各方協商確定,本次交易股權轉讓價款為1,167.00萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.